Creative Biolabs Gene Therapy Blog

Menu

Skip to content
  • Gene Therapy Research
  • Gene Therapy News

Category Archives: Gene Therapy News

28Jun/23

Gene Therapy for Hemophilia B Using Viral and Non-Viral Vectors

June 28, 2023Gene Therapy News, Gene Therapy ResearchAAV, Adeno-associated Virus, Gene Therapybiolabs

Hemophilia is a genetic disorder characterized by the deficiency of clotting factors, resulting in spontaneous or excessive bleeding during surgery or trauma. Hemophilia B is caused by the deficiency of clotting factorRead More…

23May/23

The First Drug-Repeatable Gene Therapy—Beremagene Geperpavec (B-VEC)—Approved by FDA

May 23, 2023Gene Therapy NewsB-VEC, Repeatable Gene Therapybiolabs

The FDA approved Beremagene Geperpavec (B-VEC), also known by its trade name Vyjuvke, on May 19, 2023, for the treatment of dystrophic maculopapularity in patients aged 6 months and older with epidermolysisRead More…

09May/23
The RNA editor ADAR2 promotes immune cell trafficking by enhancing endothelial responses to interleukin-6 during sterile inflammation

A New Study Uncovers How RNA Editing Directs Immune Cells to Sites of Tissue Damage

May 9, 2023Gene Therapy NewsRNA Editingbiolabs

In a recent study, researchers from the University of Heidelberg, Mannheim Medical School, and Newcastle University uncovered a novel mechanism of immune cell trafficking through the investigation of vascular disease. This knowledge mayRead More…

02Apr/23

Gene-Edited Pigs May Avoid Viral Infections in Xenografts

April 2, 2023Gene Therapy NewsGene-Edited Pigs, PERVbiolabs

Technological advances in organ transplantation have given hope to many patients with organ failure. However, the scarcity of organ donors remains a significant problem, resulting in many patients waiting for organ transplantsRead More…

17Mar/23

Activating Oligonucleotide Technology as A Therapeutic Approach in Cancer

March 17, 2023Gene Therapy News, Gene Therapy ResearchCancer, Gene Therapy, Oligonucleotide Therapybiolabs

Cell growth is strictly regulated by tumor suppressor genes (TSGs), so that cells divide only when absolutely necessary and then respond to appropriate external signals, such as growth factors. In addition toRead More…

08Jan/23

AAV Delivery of Micro DMD Gene for the Treatment of Duchenne Muscular Dystrophy in GRMD Model

January 8, 2023Gene Therapy News, Gene Therapy ResearchAAV Vector, Duchenne muscular dystrophy, Gene Therapybiolabs

Duchenne muscular dystrophy (DMD) is a monogenic disease with a relatively high prevalence, caused by mutations in the gene encoding the anti-myotonic protein (Dystrophin) on the X chromosome, resulting in the failureRead More…

25Dec/22

Novel Gene Therapy Holds Promise for Treating Children with Artemis-SCID

December 25, 2022Gene Therapy NewsNovel Gene Therapy, Reviewbiolabs

In a recent clinical study, researchers from the University of California, San Francisco, have pioneered a novel gene therapy that holds the promise of a healthier life for 10 young children whoRead More…

18Nov/22

Novel Gene Therapy Targeting Overactive Brain Cells Holds Promise for Treating Neurological Disorders

November 18, 2022Gene Therapy News, Gene Therapy ResearchGene Therapy, Neurological Disordersbiolabs

In a recent study, researchers from University College London have developed a new approach to treating neurological and psychiatric disorders that works by reducing the neuronal firing of overactive brain cells. TheRead More…

25Oct/22

AAV Gene Therapy Helps Restore Night Vision in Congenital Melanoma Patients Blind for Decades

October 25, 2022Gene Therapy News, Gene Therapy ResearchAAV Gene Therapy, Gene Therapybiolabs

The human brain mainly receives external information through five senses: sight, hearing, smell, touch, and taste, of which at least 80% of external information is obtained through vision. The loss of visionRead More…

10Jul/22

Application Highlights and Future Development Trends of Gene Editing Technologies

July 10, 2022Gene Therapy News, Gene Therapy ResearchGene Editing, Gene Therapybiolabs

What is Gene Editing? Gene editing is an emerging genetic engineering technology that can precisely modify specific target genes in an organism’s genome. Simply put, gene editing is the use of aRead More…

Posts navigation

  • « Previous
  • 1
  • 2
  • 3
  • Next »

Categories

  • Gene Therapy News
  • Gene Therapy Research
  • Uncategorized

Recent Posts

  • Breakthrough AAV Vector for Effective Brain-Wide Gene Delivery: Targeting Human Transferrin Receptor to Enhance CNS Gene Therapy
  • Breakthrough in ALS Treatment: Tofersen Significantly Slows Disease Progression in SOD1 Mutation Patient
  • Advancements in Gene Therapy: Ring Therapeutics Develops Anellovirus-Based Anellovector for Safe and Effective Treatment
  • Revolutionizing Gene Therapy: Human Liver Model Advances Preclinical Testing
  • PRINT: Enhancing Gene Therapy with Precision Retrotransposon Insertion

Archives

  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • July 2022
  • October 2020

Contact Us

USA – UK

Copyright © Creative Biolabs Gene Therapy Blog
Powered by WordPress , Theme i-max by TemplatesNext.
MENU
  • Gene Therapy Research
  • Gene Therapy News